Financials
Financial year 2025
PHARMACIE OREINS DELIVYNE from Tournai, company number BE0452092155, closed financial year 2025 with a result of € 57,532 after tax. For that financial year PHARMACIE OREINS DELIVYNE recorded a gross margin of € 229,643 and equity of € 284,661. Compared with financial year 2024, the result moved from € 58,252 to € 57,532. The company is profitable. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on June 22, 2026.
€ 284,661
▼ 14% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 57,532
▼ 1% vs 2024
Profit after tax over the fiscal year.
€ 251,011
▲ 37% vs 2024
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2025. Retained profit grew to € 223,161.
People and assets in 2025
1.9
▲ 0.5 vs 2024
Average over the fiscal year, from the social balance sheet.
€ 132,086
▲ 41% vs 2024
€ 69,500 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 2,119
▼ 47% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 56,089
▼ 10% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 31,688
▲ 73% vs 2024
Taxes, VAT and social contributions still to pay.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 152,554 | € 179,246 | € 192,636 | € 229,643 | ▲ 19% |
| Profit after taxes | € 28,070 | € 50,066 | € 58,252 | € 57,532 | ▼ 1% |
| Equity | € 223,211 | € 273,277 | € 331,529 | € 284,661 | ▼ 14% |
| Total debts | € 141,234 | € 84,253 | € 90,375 | € 201,875 | ▲ 123% |
| Cash | € 83,485 | € 40,510 | € 183,463 | € 251,011 | ▲ 37% |
| Land & buildings | € 85,324 | € 68,444 | € 51,564 | € 35,492 | ▼ 31% |
| Retained profit | € 57,311 | € 107,377 | € 165,629 | € 223,161 | ▲ 35% |
| Bank debt | € 44,804 | € 2,421 | € 0 | € 0 | |
| Balance sheet total | € 364,445 | € 357,530 | € 421,904 | € 486,536 | ▲ 15% |
| Employees (FTE) | 1.4 | 1.4 | 1.4 | 1.9 | ▲ 0.5 |
Key figures of PHARMACIE OREINS DELIVYNE, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to PHARMACIE OREINS DELIVYNE?
What happened at PHARMACIE OREINS DELIVYNE in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- Marie-Madeleine Delivyne stepped down as director. NBB
- New annual accounts for financial year 2025: profit of € 57,532 (▼ 1% vs 2024). Source: NBB ↗
- Marie-Madeleine Delivyne became a director. NBB
- New establishment in Tournai. KBO
- Start of the company according to the CBE. KBO
In short
From € 28,070 profit in 2022 to € 57,532 profit in 2025.
Paid € 54,931 in corporate taxes since 2022.
Best year ever: 2024, with € 58,252 profit.
On average € 120,900 of value added per employee in 2025.
A new publication or filing at PHARMACIE OREINS DELIVYNE? We notify you, reason included.
Follow PHARMACIE OREINS DELIVYNEDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
Directors
According to the 2025 annual accounts
Marie-Madeleine Delivyne
Director
since 2023 · until 2029
Establishments
Establishment units
Physical locations of this company
Grand'Route(G-R) 268 box A
7530 Tournai
Grand'Route(G-R) 268
7530 Tournai
Active since 2 May 1994
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0452.092.155
- VAT number
- BE 0452.092.155
- Registered office
- Grand'Route(G-R) 268 bus A, 7530 Tournai
- Names & denominations
- PHARMACIE OREINS DELIVYNE
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Normale toestand
- Start date
- 9 March 1994
- Peppol
- Active · Active since 18 Dec 2025
- Activities · NACE
Detailhandel in farmaceutische producten
Apothekers